Firefly Neuroscience annual gross margin
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Firefly Neuroscience's gross margin was 56.48% for fiscal 2025.
View full Firefly Neuroscience company overview| Fiscal year | Period ended | Gross margin | Change (percentage points) |
|---|---|---|---|
| 2025 | 2025-12-31 | 56.48% | −43.52 pp |
| 2024 | 2024-12-31 | 100.00% | −424.96 pp |
| 2023 | 2023-12-31 | 524.96% | +498.99 pp |
| 2022 | 2022-12-31 | 25.97% | +1.92 pp |
| 2021 | 2021-12-31 | 24.05% | +8.16 pp |
| 2020 | 2020-12-31 | 15.89% | +2.12 pp |
| 2019 | 2019-12-31 | 13.77% | −10.21 pp |
| 2018 | 2018-12-31 | 23.99% | +1.29 pp |
| 2017 | 2017-12-31 | 22.70% | −4.39 pp |
| 2016 | 2016-12-31 | 27.09% | −11.09 pp |
| 2015 | 2015-12-31 | 38.18% | −3.11 pp |
| 2014 | 2014-12-31 | 41.28% | +11.07 pp |
| 2013 | 2013-12-31 | 30.21% | −3.95 pp |
| 2012 | 2012-12-31 | 34.16% | +2.93 pp |
| 2011 | 2011-12-31 | 31.23% | −3.55 pp |
| 2010 | 2010-12-31 | 34.78% | — |
| Fiscal quarter | Period ended | Gross margin | Change (percentage points) |
|---|---|---|---|
| Q2 2026 | 2026-06-30 | 49.22% | −42.42 pp |
| Q1 2026 | 2026-03-31 | 45.57% | −54.43 pp |
| Q4 2025 | 2025-12-31 | 44.17% | +1240.89 pp |
| Q3 2025 | 2025-09-30 | 37.63% | −62.37 pp |
| Q2 2025 | 2025-06-30 | 91.64% | −8.36 pp |
| Q1 2025 | 2025-03-31 | 100.00% | −5727.15 pp |
| Q4 2024 | 2024-12-31 | −1,196.71% | −4021.98 pp |
| Q3 2024 | 2024-09-30 | 100.00% | +65.18 pp |
| Q2 2024 | 2024-06-30 | 100.00% | +69.59 pp |
| Q1 2024 | 2024-03-31 | 5,827.15% | +5800.56 pp |
| Q3 2023 | 2023-09-30 | 2,825.27% | +2793.25 pp |
| Q2 2023 | 2023-06-30 | 34.82% | +10.72 pp |
| Q1 2023 | 2023-03-31 | 30.41% | +7.16 pp |
| Q4 2022 | 2022-12-31 | 26.59% | +0.98 pp |
| Q3 2022 | 2022-09-30 | 32.02% | +9.26 pp |
| Q2 2022 | 2022-06-30 | 24.10% | +3.90 pp |
| Q1 2022 | 2022-03-31 | 23.25% | −6.57 pp |
| Q4 2021 | 2021-12-31 | 25.61% | −4.31 pp |
| Q3 2021 | 2021-09-30 | 22.76% | +7.10 pp |
| Q2 2021 | 2021-06-30 | 20.20% | +12.13 pp |
| Q1 2021 | 2021-03-31 | 29.82% | +16.29 pp |
| Q4 2020 | 2020-12-31 | 29.92% | +13.91 pp |
| Q3 2020 | 2020-09-30 | 15.66% | +3.59 pp |
| Q2 2020 | 2020-06-30 | 8.07% | −1.56 pp |
| Q1 2020 | 2020-03-31 | 13.52% | −13.86 pp |
| Q4 2019 | 2019-12-31 | 16.01% | −17.11 pp |
| Q3 2019 | 2019-09-30 | 12.08% | −11.45 pp |
| Q2 2019 | 2019-06-30 | 9.63% | −5.35 pp |
| Q1 2019 | 2019-03-31 | 27.39% | −12.08 pp |
| Q4 2018 | 2018-12-31 | 33.12% | +6.03 pp |
| Q3 2018 | 2018-09-30 | 23.53% | +0.25 pp |
| Q2 2018 | 2018-06-30 | 14.98% | −0.74 pp |
| Q1 2018 | 2018-03-31 | 39.47% | +5.74 pp |
| Q4 2017 | 2017-12-31 | 27.09% | −0.16 pp |
| Q3 2017 | 2017-09-30 | 23.28% | −4.09 pp |
| Q2 2017 | 2017-06-30 | 15.71% | −13.13 pp |
| Q1 2017 | 2017-03-31 | 33.74% | +9.38 pp |
| Q4 2016 | 2016-12-31 | 27.25% | −23.92 pp |
| Q3 2016 | 2016-09-30 | 27.37% | −3.08 pp |
| Q2 2016 | 2016-06-30 | 28.84% | −4.46 pp |
| Q1 2016 | 2016-03-31 | 24.36% | −8.45 pp |
| Q4 2015 | 2015-12-31 | 51.17% | +5.63 pp |
| Q3 2015 | 2015-09-30 | 30.45% | −14.06 pp |
| Q2 2015 | 2015-06-30 | 33.30% | +2.34 pp |
| Q1 2015 | 2015-03-31 | 32.81% | −5.70 pp |
| Q4 2014 | 2014-12-31 | 45.54% | +13.35 pp |
| Q3 2014 | 2014-09-30 | 44.52% | +21.04 pp |
| Q2 2014 | 2014-06-30 | 30.96% | −5.11 pp |
| Q1 2014 | 2014-03-31 | 38.50% | −0.45 pp |
| Q4 2013 | 2013-12-31 | 32.19% | −10.91 pp |
| Q3 2013 | 2013-09-30 | 23.48% | −9.35 pp |
| Q2 2013 | 2013-06-30 | 36.07% | +6.63 pp |
| Q1 2013 | 2013-03-31 | 38.96% | +3.77 pp |
| Q4 2012 | 2012-12-31 | 43.09% | +22.45 pp |
| Q3 2012 | 2012-09-30 | 32.83% | −8.22 pp |
| Q2 2012 | 2012-06-30 | 29.44% | −5.28 pp |
| Q1 2012 | 2012-03-31 | 35.18% | −3.76 pp |
| Q4 2011 | 2011-12-31 | 20.64% | −11.94 pp |
| Q3 2011 | 2011-09-30 | 41.04% | +7.71 pp |
| Q2 2011 | 2011-06-30 | 34.72% | — |
| Q1 2011 | 2011-03-31 | 38.94% | — |
| Q3 2010 | 2010-09-30 | 32.59% | — |
| Q2 2010 | 2010-06-30 | 33.33% | — |
Over the last five reported fiscal years, Firefly Neuroscience's gross margin increased from 15.89% to 56.48%, a change of +40.59 percentage points. The latest reported quarter, Q2 2026, shows 49.22%.
Gross margin measures the percentage of revenue remaining after the direct costs of producing goods or services. It helps show how efficiently a company turns sales into gross profit before operating expenses.
TickerStat calculates gross margin as SEC-reported gross profit divided by SEC-reported revenue for the same fiscal period. Changes are shown in percentage points. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Firefly Neuroscience filings at SEC.gov ↗